HK Stock Market Move | REFIRE (02570) rose more than 8% and will face a lifting of the restriction on Monday. The company focuses on hydrogen fuel cell systems.
Reshape Energy (02570) surged over 8%, as of the time of writing, it rose 8.3% to HK$122.6, with a turnover of HK$160 million.
REFIRE (02570) surged more than 8%, as of the time of this report, it rose by 8.3% to 122.6 Hong Kong dollars, with a trading volume of 160 million Hong Kong dollars.
On the news front, REFIRE is about to face a lock-up expiration. According to a previous announcement by the company, the last day of the lock-up period for pre-IPO investors and existing shareholders is December 5, 2025. Public information shows that REFIRE focuses on the design, development, manufacturing, and sales of hydrogen fuel cell systems, hydrogen equipment, and related components, as well as providing hydrogen fuel cell engineering development services. According to data from Frost & Sullivan, REFIRE ranks first in the Chinese hydrogen fuel cell system market in terms of total output power of heavy-duty truck hydrogen fuel cell systems sold in 2023, total sales output power, and total sales revenue, with market shares of 23.8%, 42.4%, and 29.4% respectively.
Related Articles

Lenovo (00992) announced the expansion of Neptune liquid cooling technology to its entire data center product portfolio.

HK Stock Market Move | SKB BIO-B(06990) rose nearly 3% and established a strategic partnership with Crescent to jointly develop cancer treatment methods.

Strong performance confirms strategic success! Dollar General Corporation(DG.US) is highly regarded on Wall Street, with a target price of up to $140.
Lenovo (00992) announced the expansion of Neptune liquid cooling technology to its entire data center product portfolio.

HK Stock Market Move | SKB BIO-B(06990) rose nearly 3% and established a strategic partnership with Crescent to jointly develop cancer treatment methods.

Strong performance confirms strategic success! Dollar General Corporation(DG.US) is highly regarded on Wall Street, with a target price of up to $140.






